Why the study?
Does a phosphorylcholine-coated cardiopulmonary bypass circuit reduce blood loss and preserve platelet function in adults undergoing CABG or mitral valve repair?
Does a phosphorylcholine-coated cardiopulmonary bypass circuit reduce blood loss and preserve platelet function in adults undergoing CABG or mitral valve repair?
The use of a phosphorylcholine-coated cardiopulmonary bypass circuit reduces early postoperative bleeding in patients undergoing cardiac surgery, though it does not significantly alter measurable platelet function.
No takes yet. Share an insight, caveat, or question.
PC-coated circuits reduce early blood loss after CABG or mitral repair; extends biocompatibility evidence without altering platelet function.
Marguerite et al. (2012) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: